GlassScriptPhysician profile
Jonathan H Todd
NPI 1003347691
$881.58
in general payments reported to CMS, 2019-2025
11 companies · $382 in 2025
The $382 reported for 2025 was more than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $14.44 · 2021: $32.26 · 2022: $142 · 2023: $81.41 · 2024: $229 · 2025: $382.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $693.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $692.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $227.23 | 2023-2025 | Qelbree, Qelbree |
| Corium, LLC | $226.11 | 2022-2025 | Azstarys |
| Takeda Pharmaceuticals U.S.A., INC. | $101.80 | 2020-2022 | |
| E.R. Squibb & Sons, L.L.C. | $65.72 | 2025 | Cobenfy |
| Tris Pharma INC | $64.99 | 2024-2025 | Dyanavel Xr, Quillivant, Quillichew Er |
| Collegium Pharmaceutical, INC. | $63.84 | 2025 | Jornay Pm |
| Ironshore Pharmaceuticals INC. | $39.87 | 2024 | |
| Otsuka America Pharmaceutical, INC. | $29.39 | 2023-2024 | Abilify Maintena, Abilify Asimtufii |
| Janssen Pharmaceuticals, INC | $23.70 | 2025 | Spravato |
| Alkermes, INC. | $22.95 | 2022 | |
| Vertical Pharmaceuticals, LLC | $15.98 | 2025 | Relexxii |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Todd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.